Use cost per successfully fulfilled patient-month as an operational measure—not cost per “successfully treated” patient. Our recommended definition is an enrolled patient whose expected medicine supply arrived within the agreed window, with clinical holds reported separately. Fulfilment is not a clinical outcome.
| Measure | Recommended definition | Decision supported |
|---|---|---|
| Clinic-controlled cost | Clinic-paid medicine, platform, delivery, handling and attributable rework costs | What procurement can actually negotiate |
| Patient medicine expenditure | Patient-paid medicine and associated dispensing or delivery charges | Affordability and communication |
| First-fill completion | Eligible starts reaching confirmed fulfilment | Onboarding performance |
| Fulfilment exceptions | Delays, failed delivery, clarification and payment failures, by cause | Partner remediation |
| Concentration exposure | Share of expected fills dependent on each verified dispensing facility | Continuity planning |
| Transition readiness | Alternative route tested for product, state, workflow and capacity | Whether an exit plan is executable |
Before renewal: request anonymised performance evidence, a fully itemised quotation and a named escalation process. Public programme pages do not establish your negotiated service level or a supplier’s available capacity.
Suggested reader response: bring two redacted quotations to the next comparison exercise. Exclude patient identifiers and prescription images.
Explore the table row by row
A working view of the research
Clinic-controlled cost
- Recommended definition
- Clinic-paid medicine, platform, delivery, handling and attributable rework costs
- Decision supported
- What procurement can actually negotiate
Sources cited on this page
See the section’s source register for the research context.
Section sources →